您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[港股财报]:药明康德2023年度报告 - 发现报告

药明康德2023年度报告

2024-04-26港股财报M***
药明康德2023年度报告

WuXi AppTec Co., Ltd.* 2359 2023 245635364469117123125127129132263 88135 288 3485 201 81–38 8 1283 1151509 118 28824 333 A 50147 188 H 33 1617 A603259H02359 47917 www.wuxiapptec.com.cn 2023400100CRDMOCTDMO 2024318 1. A. 40,340.82.5%10,690.221.3% CRDMOCTDMO 323020231,200126,000202318%261.342%47.012%73.71%21.48%98%396.330%7.120161.144%18%242.3374.727%93% 40,340.820222.5% (1)WuXi Chemistry 291.71.1%36.1%(R)426%CRDMO12%(D&M)D&M216.20.1%D&M55.1%20231,2552023D&M3,2016166III326II2,748IIII2020241TIDESTIDES34.164.4%2023TIDES226%2023TIDES D&M14036%26741%2024132,000L (2)WuXi Testing 65.414.4%47.815.3%27.3%55,000m22023GLP20,000m2mRNACROSMO17.611.8%SMO26.1%2023SMO54SMO2023CRO215 (3)WuXi Biology 25.53.1%3,00092002021900202326%27.5%HTS/DEL/ASMS/FBDD/CADDDELvision-DEL–202320% (4)WuXi ATU CTDMO13.10.1%CTDMO20236415III129II49I2024222023CAR-T(LVV)(BLA)(CFDI) LVV202311(TIL)BLAFDA(PLI)2024220236CAR-TLVV2024CAR-TBLA20242024FDA (5)WuXi DDSU 7.325.1%20233212202311101202318IND25(CTA)190IND169CTA324III32II73I17IND5 2024383-4052.7-8.6% 20242024 16,372.5202212.9%40.6%3.7 (1)WuXi Chemistry 12,794.84.3 (2)WuXi Testing 2,429.52.5 (3)WuXi Biology 1,026.51.6 (4)WuXi ATU 157.63.9 (5)WuXi DDSU 258.29.5 2022644.32023962.549.4%(1)253.6(2)34.9 20221,211.720231,350.3(1)WuXi XDC Cayman Inc.)1,097.6(2)549.7(3)275.8(4)155.1 2022117.32023240.9105.4% 202312,641.2202223.6% 20236,817.0202226.8% 20233,939.22022210.0% 2023123118,151.92022123117,763.740.4%24.3%10.8%24.5% (1) 202312314,408.7 (2) 202312311.6202212311.812.4% (3) 20231231 (4) 2023123124.6%2022123127.5% B. (i)(ii)(iii) D. 2023123111.0 (1)(2)(3)(4) 560.1 20231231 Genesis Medtech Group LimitedGenesis Genesis202312311,597.22.2% Genesis20231231Genesis1,5442,00050% iKang Healthcare GroupiKang iKang20231231473.40.6% iKang2019120231231iKang59166iKang200800 20231231289.80.4% 2011CRO20231231185.60.3% 20231231170.30.2% (RDC)FIC/BICBR-02FDACDEINDIITRDCRDC 202312315% E. (1) (2) PROTAC (3) 20 55,0002023GLP20,0002024132,000L20241 (4) 202040% 5BOLD1006516203418 (5) F. (1)2018 A2019AA 2018A 20234242018A112018A131,328AA0.005%0.004%A2023582023424 2019A 2023312019A12019A41,812AA0.002%0.001%A202337202331 20233202019A122019A101,376AA0.004%0.003%A20233242023320 20236272019A1,6822019A5,402,050AA0.211%0.182%A2023732023627 (2)2019 20192019202261620235253341,905,84038.622022610 20192019202362720245253111,690,93338.622023619 2023123133320191,904,55525320191,240,437AAA(T)(T+1)A(T+2)202373202412 (3)2019AA 20222019AA17.452019AA32.152023627 (4)2019 A 2019A1055,27720192023526 (5)2019 AA 2019AA2019A101A17.45201924,357A202362720231020 (6)3002024 100,000104,519.3820234420234172023315202344 (7)2022 20235312022202220222023613108.926620234272023531 (8)2021H2021 103,69920212021212021H0.0262%0.0035%2023113 (9)2022H2022 122,87820222022262022H0.0305%0.0041%2023627 (10)2023H 202353120222023H202320232023H 2023H202312122023HH(i)15,467,500HH(ii)15,467,500H15,467,500 20241520242024A2024H2023HH2024115H2024118 2023424202310302023121220241182023427202312132023531202415 A. 20237Frost & Sullivan20222,41520273,3576.8% Frost & Sullivan202247.1%202757.0%CDMO20221,33020272,52013.6% B. (1)(2)(3)(4)(5) C. 2024 (1) (2) (3) 2024 (4) PROTAC (5) (1)(2)(3)(4) (6) D. (1) (2) (3) CRO/CDMO (4) (5) 2024362024S.355820241261292421337 (6) (7) (8) (9) (10) 201820192020 12525 3 5719932000PharmacopeiaInc.20002269.HK 5420VertexPharmaceuticals Inc.2008 61198319851988198919891990Jurid Bremsbrag GmbH1996199819982000Biogen Inc.BIIB.NASDAQ20002007Tanox,Inc.TNOX.NASDAQ20072616.HK1228.HK2269.HKViela Bio, Inc.VIE.NASDAQAmbrx Biopharma Inc.AMAM.NYSE Carnegie Mellon University 5519971999Strategic Decisions Group19992001IntraBiotics2001200620072010PFE.NYSE20112014AZR.NYSE2014 54199119931993199519951998199820002000 50199820002000200820082011201151060.HK 56199620082008200920092013201310201412269.HK 551520072021WuXi PharmaTech (Cayman) Inc.WXPactera Technology International Ltd.PACTXueda Education GroupXUEWuXi Biologics (Cayman) Inc.(2269.HK) 1990719944 7030201920062018(300642.SZ) 198211988819928 462010(601595.SH)(603610.SH)(000509.SZ)(603728.SH) 199972002320105 60200481987198919942004PestalozziBaker & McKenzie(002435.SZ) 198471987719933 4820153201822021122004420141208285 19976 572017319911995GTI1996200520052023 592020820002019 52201732001 4920221120214201519972002 (EFLP) 6019901995BMS19951997Vion Pharma19982004Eli Lilly and Company20042024 3520136201642016520189201810 ————— C1 20231231C.2.1F.2.2 C3 20231231 1252520231231 1 2345678910 1.20235162.20235313.20235314.20235315.20235316.20235312023667.20235312023668.2023531202366 9.2023531202366 10.202366 202312312023693.09D 2023123113122024318122024318 20163232017317 C.2.1 20231231 3.13 1— 525 B.2.2 20231231 20231231 1. AB 102 372 41-5051-6061-70 525 5412 246 471 43113 (1) (2) (3) (4) (a) (b) (c) (d) (5) (6) (